Team

Leadership

Dirk Thye, M.D.

Chief Executive Officer, Chief Medical Officer, and Board Member

Charles Ryan, J.D., Ph.D.

President

Brendan Hannah, M.B.A.

Chief Operating Officer & Chief Business Officer

Giovanni Mambrini, MSc

Chief Technology Officer

Pamela Williamson, RAC, FRAPS, M.B.A

Head of Regulatory Affairs

Maureen Roden, M.S.N.

Vice President, Clinical Development

Gary Ward, Ph.D.

Vice President, CMC Management

Mary Ellen Sillivos, SPHR

Vice President, Human Resources

Stacy Roughan

Vice President, Corporate Communications & Investor Relations

Board of Directors

David Lamond

President, En Pointe, LLC

Dirk Thye, M.D.

Chief Executive Officer, Quince Therapeutics

Luca Benatti, Ph.D.

Director, Newron Pharmaceuticals S.p.A, Intercept Pharmaceutical, and CasRevolution

June Bray

Previously SVP, Global Regulatory Affairs and Medical Writing, Allergan

Margaret McLoughlin, Ph.D.

Previously Executive Director Worldwide Business Development, Pfizer

Rajiv Patni, M.D.

Former Reata Pharmaceuticals Chief Research & Development Officer

Una Ryan, OBE, Ph.D.

Previously Chief Executive Officer, AVANT Immunotherapeutics

Christopher Senner

Chief Financial Officer, Exelixis

Scientific Advisory Board

Mauro Magnani, Ph.D.

University of Urbino, Italy

Carlo Brugnara, M.D.

Harvard Medical School & Boston Children’s Hospital

William Jusko, Ph.D.

Buffalo University Jacobs School of Medicine and Biomedical Sciences

Howard Lederman, M.D., Ph.D.

Johns Hopkins University School of Medicine & Johns Hopkins Medical Center

Vladimir Muzykantov, M.D., Ph.D.

University of Pennsylvania, Philadelphia & Perelman School of Medicine, UPENN

Susan Perlman, M.D.

David Geffen School of Medicine at the University of California, Los Angeles & UCLA Health

James Spudich, Ph.D.

Stanford University School of Medicine

William Whitehouse, M.D.

School of Medicine at the University of Nottingham, England